Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $157.0000 (-0.78%) ($157.0000 - $157.0000) on Fri. Jul. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.05% (three month average) | RSI | 53 | Latest Price | $157.0000(-0.78%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 1.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(49%) XBI(42%) ARKG(35%) IWO(34%) ARKK(31%) | Factors Impacting SGEN price | SGEN will decline at least -1.025% in a week (0% probabilities). VIXM(-24%) VXX(-10%) UUP(-8%) TBT(-3%) USO(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.025% (StdDev 2.05%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $158.68(-1.06%) | 10 Day Moving Average | $158.14(-0.72%) | 20 Day Moving Average | $156.65(0.22%) | To recent high | -3% | To recent low | 16.2% | Market Cap | $27.297b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |